| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -30,262 | -25,394 |
| Proceeds from sale of property and equipment | 288 | 283 |
| Maturities of investments | 40,076 | 47,000 |
| Purchases of investments | - | 34,621 |
| Net cash provided by investing activities | 40,364 | 12,662 |
| Net decrease in cash and cash equivalents | 10,102 | -12,732 |
| Effect of exchange rate changes on cash | 4,547 | - |
| Cash and cash equivalents at beginning of period | 35,015 | - |
| Cash and cash equivalents at end of period | 49,664 | - |
LAVA Therapeutics NV (LVTX)
LAVA Therapeutics NV (LVTX)